L&T Technology Services Limited (LTTS), a subsidiary of Larsen & Toubro, has announced the launch of PLxAI, its proprietary Generative AI-based framework designed to accelerate the Product Development Life Cycle (PDLC) for global clients. The launch was formally disclosed to the stock exchanges on August 21, 2025.

The company said that PLxAI combines Generative AI and conventional AI to provide scalable and reusable solutions across all stages of product development — from concept design to aftermarket support. With advanced features such as capturing organizational and tribal knowledge, PLxAI aims to deliver context-aware insights that optimize engineering efficiency.

According to LTTS, the framework enhances product engineering through smart prompting and contextual intelligence, and has already been deployed across more than 36 use cases, with another 35 currently in the design phase. These use cases span multiple areas, including competitive benchmarking, component design automation, design validation planning, customizable FMEA generation, digital twin integration, and agentic workflows that automate multi-step engineering tasks.

Commenting on the launch, Alind Saxena, President & Executive Director – Mobility & Tech at LTTS, said, “This is a proud milestone for Team LTTS. The development of PLxAI by our in-house AI experts is a testimony to LTTS’ engineering and technology capabilities. It reaffirms our deep commitment toward driving global client success across Mobility, Sustainability and Tech leveraging the power of AI and Gen-AI based offerings.”

With deployments already underway across multiple domains, LTTS highlighted that PLxAI is expected to significantly accelerate innovation, reduce costs, and redefine how businesses approach product development, thereby unlocking new pathways for growth and efficiency.

L&T Technology Services, which serves 69 Fortune 500 companies and 57 top ER&D firms globally, employs over 23,600 people across 23 global design centers, 30 sales offices and 105 innovation labs as of June 30, 2025.